Transvaginal Mesh Devices Reassessed: FDA Panel Set For September

Industry, physicians and FDA are all prepping for what is likely to be a major meeting in the lifecycle of transvaginal surgical mesh devices early next month.

More from Archive

More from Medtech Insight